Welcome to the European Neuroendocrine Tumor Society

Founded in 2004, ENETS is the leading and longest-established society dedicated to improving the diagnosis and treatment of neuroendocrine tumours (NETs). It has over 1,500 members from various medical disciplines, including oncology, endocrinology, gastroenterology, nuclear medicine, pathology, radiology, surgery, and basic/translational science.

Our mission is to raise awareness, advance research, and foster collaboration in the NET field.

ENETS provides accredited educational programmes, including conferences, webinars, and e-learning – designed by experts for healthcare professionals. Our vibrant, multidisciplinary community extends well beyond Europe, united in the goal of improving NET diagnosis, treatment, and care.

ENETS CoE Preceptorship 2026 – Open Grant Call

The ENETS CoE Preceptorship 2026 grant is now open! This is a unique opportunity to gain hands-on experience and expert mentorship in the field of neuroendocrine tumors. Enhance your skills and expand your network by working alongside leading specialists in the field.
Deadline: 15 October 2026.

Find out more

ENETS News

All newsletters

JNE reaches Impact Factor 5.0

A new milestone for ENETS' home journal: The Journal of Neuroendocrinology's Impact Factor has increased from 4.1 to 5.0, with Q1 rankings in both Endocrinology & Metabolism and Neurosciences.

Read full announcement

Webinar Archive

Missed our recent webinar? No worries! You can catch up on all the valuable insights by watching the recording in our ENETS Webinar Archive. Stay up to date and enhance your knowledge at your own pace.

Discover past webinars

ENETS Publications

New ENETS Guidance Paper

We are pleased to announce the publication of the ninth ENETS guidance paper in the Journal of Neuroendocrinology, focusing on the diagnosis and management of lung and thymic carcinoids.

This paper provides practical, evidence-graded recommendations, addressing key clinical questions in a structured question-and-answer format. It is freely available open access.

Discover all ENETS guidelines

NENs Policy Recommendations

At the 2024 ENETS Annual Conference, a roundtable discussion brought together physicians, patients and EU policymakers to address key barriers to high-quality NEN care across Europe, aligned with the 2023 ENETS-endorsed publication.

ENETS extends its thanks to all contributors and is pleased to support this important initiative.

Read the policy recommendations

SurvivApp Study

ENETS is proud to announce the publication of the ENETS-endorsed SurvivApp study, titled “Hemicolectomy versus Appendectomy for Patients with Appendiceal Neuroendocrine Tumours 1–2 cm in Size: A Retrospective, Europe-wide, Pooled Cohort Study” in Lancet Oncology.

We congratulate and thank everyone involved in this important research and are delighted to have supported this significant initiative.

Read the article at The Lancet Oncolody

Latest Controversies in NEN

A new ENETS position statement has been published in the Journal of Neuroendocrinology on 30 June 2026. Part of the Controversies in Neuroendocrine Neoplasms series, the paper by Deroose et al. provides expert consensus and practical guidance on the clinical use and interchangeability of somatostatin receptor PET tracers.

The paper is freely accessible for a limited period following publication and will subsequently be available to ENETS members via myENETS.

Discover ENETS consensus papers

BS & TS Task Force Whitepaper

ENETS is excited to announce the publication of the basic and translational science task force whitepaper: White paper on best practices for translational research in neuroendocrine neoplasms

Published in the Journal of Neuroendocrinology on 28 July 2025.

Read JNE article

MEN1 Task Force Study

ENETS is excited to announce the publication of its MEN1 Task Force study: Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE) — An ENETS MEN1 task force questionnaire study.

Published in the Journal of Neuroendocrinology on 26 November 2024.

Read JNE article

Membership matters

Multidisciplinary is our credo. We welcome all NET-related disciplines and professionals! Learn more about the benefits of becoming an ENETS member.

Learn more

Support ENETS

Any donation made to ENETS charity, no matter what size, will help to support us with our many projects. ENETS wants to ensure that neuroendocrine cancer patients in Europe get a timely diagnosis, the best level of care and ultimately, a cure. Click below to read more.

Donate now

ENETS FACTS

22 Annual Conferences
Since 2004
3 Hybrid conferences from 2022 - 2024
5 Virtual conferences
between 2020 - 2024
1,610 Currently registered members